Blauvelt, A., Fowler, Jr., J.F., Schuck, E., Jauch, J., Woehling, H. and Leonardi, C.L. 2017. A Randomized, Double-Blind, Multicenter Study to Compare the Efficacy, Safety, and Immunogenicity of a Proposed Adalimumab Biosimilar (GP2017) with Originator Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s29. DOI:https://doi.org/10.25251/skin.1.supp.28.